0001752724-20-205284.txt : 20201013
0001752724-20-205284.hdr.sgml : 20201013
20201013090332
ACCESSION NUMBER: 0001752724-20-205284
CONFORMED SUBMISSION TYPE: N-CEN
PUBLIC DOCUMENT COUNT: 2
CONFORMED PERIOD OF REPORT: 20200731
FILED AS OF DATE: 20201013
DATE AS OF CHANGE: 20201013
EFFECTIVENESS DATE: 20201013
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: AB PORTFOLIOS
CENTRAL INDEX KEY: 0000812015
IRS NUMBER: 000000000
FISCAL YEAR END: 0831
FILING VALUES:
FORM TYPE: N-CEN
SEC ACT: 1940 Act
SEC FILE NUMBER: 811-05088
FILM NUMBER: 201234855
BUSINESS ADDRESS:
STREET 1: ALLIANCEBERNSTEIN LP
STREET 2: 1345 AVENUE OF THE AMERICAS
CITY: NEW YORK
STATE: NY
ZIP: 10105
BUSINESS PHONE: 2129691000
MAIL ADDRESS:
STREET 1: ALLIANCEBERNSTEIN LP
STREET 2: 1345 AVENUE OF THE AMERICAS
CITY: NEW YORK
STATE: NY
ZIP: 10105
FORMER COMPANY:
FORMER CONFORMED NAME: ALLIANCEBERNSTEIN PORTFOLIOS
DATE OF NAME CHANGE: 20030319
FORMER COMPANY:
FORMER CONFORMED NAME: ALLIANCE PORTFOLIOS
DATE OF NAME CHANGE: 19930812
FORMER COMPANY:
FORMER CONFORMED NAME: EQUITABLE FUNDS
DATE OF NAME CHANGE: 19920703
0000812015
S000010509
AB Growth Fund
C000028997
Class A
AGRFX
C000028998
Class B
AGBBX
C000028999
Class C
AGRCX
C000029000
Advisor Class
AGRYX
C000029001
Class R
AGFRX
C000029002
Class K
AGFKX
C000029003
Class I
AGFIX
N-CEN
1
primary_doc.xml
X0303
N-CEN
LIVE
0000812015
XXXXXXXX
811-05088
false
false
false
N-1A
S000010509
C000028999
C000029002
C000028997
C000029001
C000028998
C000029003
C000029000
AB PORTFOLIOS
811-05088
0000812015
549300SL79FN46SWRF45
ALLIANCEBERNSTEIN LP
1345 AVENUE OF THE AMERICAS
NEW YORK
10105
US-NY
US
212-969-1000
State Street Bank and Trust Company
1 Lincoln Street
Boston
02111
617-786-3000
Custody and Accounting Records
N
N
N-1A
6
Y
Michael J. Downey
000000000
N
Garry L. Moody
000000000
N
Earl D. Weiner
000000000
N
Jeanette Loeb
000000000
N
Nancy P. Jacklin
000000000
N
Carol C. McMullen
000000000
N
Jorge A. Bermudez
000000000
N
Marshall C. Turner, Jr.
000000000
N
Robert M. Keith
002309907
Y
Vincent S. Noto
000000000
1345 Avenue of the Americas
New York
10105
XXXXXX
N
N
N
N
N
N
AllianceBernstein Investments, Inc.
8-30851
000014549
0000000000
Y
N
Ernst & Young LLP
42
00000000000000000000
N
N
N
N
N
N
N
AB Growth Fund
S000010509
549300UM1VFAB7ZJOJ94
N
8
0
0
N/A
N
N
Y
N
N
State Street Bank and Trust Company
571474TGEMMWANRLN572
N
N
Revenue sharing split
89743111.14000000
123847.00000000
Rule 32a-4 (17 CFR 270.32a-4)
Rule 12d1-1 (17 CFR 270.12d1-1)
Rule 22d-1 (17 CFR 270.22d-1)
Y
Y
N
N
AllianceBernstein L.P.
801-56720
000108477
0JK55UGWSWNF3X7KLQ85
N
AllianceBernstein Investor Services, Inc.
084-01187
0000000000
Y
N
N
Refinitiv US Holdings Inc.
549300NF240HXJO7N016
N
Vertical Management Systems, Inc.
27-3275288
Tax ID
N
ICE Data Services, Inc.
13-3668779
Tax ID
N
Standard & Poor's Financial Services LLC
549300U4VWNITEKO2881
N
PricingDirect Inc.
549300WIC0TOJ7N7GD54
N
Bloomberg L.P.
549300B56MD0ZC402L06
N
IHS Markit Ltd.
549300HLPTRASHS0E726
GB
N
N
Deutsche Bank Societa per Azioni
529900SS7ZWCX82U3W60
IT
N
Y
Foreign custodian - rule 17f-5 (17 CFR 270.17f-5)
Mizuho Bank, Ltd. (Minato ku, Tokyo, JP, Branch)
RB0PEZSDGCO3JS6CEU02
JP
N
Y
Foreign custodian - rule 17f-5 (17 CFR 270.17f-5)
State Street Bank and Trust Company (Edinburgh, GB, Branch)
571474TGEMMWANRLN572
GB
N
Y
Foreign custodian - rule 17f-5 (17 CFR 270.17f-5)
State Street Bank and Trust Company
571474TGEMMWANRLN572
N
N
Bank - section 17(f)(1) (15 U.S.C. 80a-17(f)(1))
Deutsche Bank Aktiengesellschaft (Amsterdam, Noord Holland, NL, Branch)
7LTWFZYICNSX8D621K86
NL
N
Y
Foreign custodian - rule 17f-5 (17 CFR 270.17f-5)
Clearstream Banking S.A.
549300OL514RA0SXJJ44
LU
N
Y
Foreign securities depository - rule 17f-7 (17 CFR 270.17f-7)
UBS Switzerland AG
549300WOIFUSNYH0FL22
CH
N
Y
Foreign custodian - rule 17f-5 (17 CFR 270.17f-5)
N
AllianceBernstein Investor Services, Inc.
0000000000
Y
N
N
AllianceBernstein L.P.
0JK55UGWSWNF3X7KLQ85
Y
N
N
Sanford C. Bernstein Limited
N/A
000000000
54930049G8WQ5OOUSD19
GB
0.00000000
Sanford C. Bernstein & Co., LLC
8-52942
000104474
549300I7JYZHT7D5CO04
0.00000000
Morgan Stanley & Co. LLC
8-15869
000008209
9R7GPTSO7KV3UQJZQ078
9734.96000000
Cowen and Company, LLC
8-22522
000007616
549300WR155U7DVMIW58
17972.07000000
Citation Group Ltd.
8-43632
000028305
00000000000000000000
8371.68000000
Credit Suisse Securities (USA) LLC
8-422
000000816
1V8Y6QCX6YMJ2OELII46
11981.85000000
J.P. Morgan Securities LLC
8-35008
000000079
ZBUT11V806EZRVTWT807
8557.13000000
Virtu Itg LLC
8-44218
000029299
549300S41SMIODVIT266
3351.03000000
UBS Securities LLC
8-22651
000007654
T6FIZBDPKLYJKFCRVK44
8738.63000000
Citigroup Global Markets Inc.
8-8177
000007059
MBNUM2BPBDO7JBLYG310
9286.74000000
Barclays Capital Inc.
8-41342
000019714
AC28XWWI3WIBK2824319
8958.29000000
Goldman Sachs & Co. LLC
8-129
000000361
FOR8UP27PHTHYVLBNG30
18767.34000000
116505.78000000
State Street Bank and Trust Company
N/A
000000000
571474TGEMMWANRLN572
619020534.93000000
619020534.93000000
Y
1192747255.58000000
Committed
325000000.00000000
N
N
N
N
true
INTERNAL CONTROL RPT
2
NCEN_2196581506781068.txt
Report of Independent Registered Public
Accounting Firm
To the Shareholders and Board of Trustees of AB
Growth Fund:
In planning and performing our audit of the
financial statements of AB Growth Fund, (the
"Fund"), (one of the series constituting The AB
Portfolios, as of and for the year ended July 31,
2020, in accordance with the standards of the Public
Company Accounting Oversight Board (United
States), we considered the Fund's internal control
over financial reporting, including controls over
safeguarding securities, as a basis for designing our
auditing procedures for the purpose of expressing
our opinion on the financial statements and to
comply with the requirements of Form N-CEN, but
not for the purpose of expressing an opinion on the
effectiveness of the Fund's internal control over
financial reporting. Accordingly, we express no
such opinion.
The management of the Fund is responsible for
establishing and maintaining effective internal
control over financial reporting. In fulfilling this
responsibility, estimates and judgments by
management are required to assess the expected
benefits and related costs of controls. A company's
internal control over financial reporting is a process
designed to provide reasonable assurance regarding
the reliability of financial reporting and the
preparation of financial statements for external
purposes in accordance with U.S. generally
accepted accounting principles. A company's
internal control over financial reporting includes
those policies and procedures that (1) pertain to the
maintenance of records that, in reasonable detail,
accurately and fairly reflect the transactions and
dispositions of the assets of the company; (2)
provide reasonable assurance that transactions are
recorded as necessary to permit preparation of
financial statements in accordance with U.S.
generally accepted accounting principles, and that
receipts and expenditures of the company are being
made only in accordance with authorizations of
management and trustees of the company; and (3)
provide reasonable assurance regarding prevention
or timely detection of unauthorized acquisition, use
or disposition of a company's assets that could have
a material effect on the financial statements.
Because of its inherent limitations, internal control
over financial reporting may not prevent or detect
misstatements. Also, projections of any evaluation
of effectiveness to future periods are subject to the
risk that controls may become inadequate because
of changes in conditions, or that the degree of
compliance with the policies or procedures may
deteriorate.
A deficiency in internal control over financial
reporting exists when the design or operation of a
control does not allow management or employees,
in the normal course of performing their assigned
functions, to prevent or detect misstatements on a
timely basis. A material weakness is a deficiency, or
a combination of deficiencies, in internal control
over financial reporting, such that there is a
reasonable possibility that a material misstatement
of the company's annual or interim financial
statements will not be prevented or detected on a
timely basis.
Our consideration of the Fund's internal control
over financial reporting was for the limited purpose
described in the first paragraph and would not
necessarily disclose all deficiencies in internal
control that might be material weaknesses under
standards established by the Public Company
Accounting Oversight Board (United States).
However, we noted no deficiencies in the Fund's
internal control over financial reporting and its
operation, including controls over safeguarding
securities that we consider to be a material
weakness as defined above as of July 31, 2020.
This report is intended solely for the information
and use of management and the Board of Trustees
of AB Growth Fund and the Securities and
Exchange Commission, and is not intended to be
and should not be used by anyone other than these
specified parties.
/s/ ERNST & YOUNG LLP
New York, New York
September 25, 2020